ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 525.68B
Enterprise value 321.98B
Trailing P/E 10.98
Forward P/E 19.95
PEG Ratio (5 yr expected) 10.87
Price/sales (ttm)4.85
Price/book (mrq)2.19
Enterprise value/revenue 34.15
Enterprise value/EBITDA 68.05

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 32.01%
S&P500 52-week change 38.60%
52-week high 3134.84
52-week low 372.67
50-day moving average 3103.36
200-day moving average 3102.18

Share statistics

Avg vol (3-month) 32.71M
Avg vol (10-day) 33.47M
Shares outstanding 5220.83M
Float 220.19M
% held by insiders 10.30%
% held by institutions 195.39%
Shares short (14-May-2020) 44.75M
Short ratio (14-May-2020) 42
Short % of float (14-May-2020) 42.24%
Short % of shares outstanding (14-May-2020) 42.15%
Shares short (prior month 14-Apr-2020) 44.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 322-May-2011

Financial highlights

Fiscal year

Fiscal year ends 30-Dec-2019
Most-recent quarter (mrq)30-Mar-2020


Profit margin 44.83%
Operating margin (ttm)44.97%

Management effectiveness

Return on assets (ttm)9.26%
Return on equity (ttm)22.13%

Income statement

Revenue (ttm)5.3B
Revenue per share (ttm)23.78
Quarterly revenue growth (yoy)26.70%
Gross profit (ttm)4.6B
Net income avi to common (ttm)2.37B
Diluted EPS (ttm)10.59
Quarterly earnings growth (yoy)-5.20%

Balance sheet

Total cash (mrq)2.36B
Total cash per share (mrq)10.7
Total debt (mrq)2.85B
Total debt/equity (mrq)24.24
Current ratio (mrq)4.35
Book value per share (mrq)53.13

Cash flow statement

Operating cash flow (ttm)2.2B
Levered free cash flow (ttm)1.54B